SCHEMBL1014108

SCHEMBL1014108

Cc1c(C)c(C)c2c(c1C)Sc1ccccc1S2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.37
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ACHE P22303 3/20 0.35
NOX1 Q9Y5S8 3/20 0.35
ALOX12 P18054 2/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
BCHE P06276 2/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ALOX15 P16050 1/20 0.35
CNR1 P21554 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2C P28335 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11592093 0.87 MAOA (0.30) MAOAMEN1KMT2AACHE
SCHEMBL11591284 0.87 MAOA (0.30) MAOAMEN1KMT2A
SCHEMBL11593916 0.82 ACHE (0.34) MAOAMEN1KMT2AACHETSHR
SCHEMBL11386267 0.82 MAOA (0.30) MAOAMEN1KMT2A
SCHEMBL11591258 0.82 MAOA (0.30) MAOAMEN1KMT2A
SCHEMBL3422316 0.78 MEN1 (0.43) MAOAMEN1KMT2AACHENOX1
SCHEMBL11593911 0.77 CYBB (0.30) NOX1
SCHEMBL11594804 0.77 ACHE (0.34) MAOAMEN1KMT2AACHETSHR
SCHEMBL11592760 0.77 MAOA (0.30) MAOAMEN1KMT2A
SCHEMBL9804804 0.75 ALOX5 (0.38) MAOAMEN1KMT2AACHENOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11758809-B2 Compound, display panel, and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-09-12 US disclosed
EP-2791293-B1 PREPARATION OF A POST-TREATED MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME CHEVRON ORONITE CO (US) 2018-09-26 EP disclosed
EP-2271652-B1 PREPARATION OF A MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME CHEVRON ORONITE CO (US) 2018-04-25 EP disclosed
EP-2483284-B1 PREPARATION OF A SULFURIZED MOLYBDENUM AMIDE COMPLEX AND ADDITIVE COMPOSITIONS HAVING LOW RESIDUAL ACTIVE SULFUR CHEVRON ORONITE CO (US) 2017-03-15 EP disclosed
CN-102510866-B There is the moly-sulfide amide complex of low residue active sulphur and the preparation of compositions of additives CHEVRON ORONITE Co.,LLC (US) 2016-02-03 CN disclosed
EP-2935543-A1 A POST-TREATED MOLYBDENUM IMIDE ADDITIVE COMPOSITION, METHODS OF MAKING SAME AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME Chevron Oronite Company LLC (US) 2015-10-28 EP disclosed
CN-104884594-A A POST-TREATED MOLYBDENUM IMIDE ADDITIVE COMPOSITION, METHODS OF MAKING SAME AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME CHEVRON ORONITE CO 2015-09-02 CN disclosed
CN-102015741-B Preparation of a molybdenum amide additive composition and lubricating oil compositions containing same CHEVRON ORONITE CO 2015-06-10 CN disclosed
EP-2872607-A1 POST-TREATED MOLYBDENUM IMIDE LUBRICATING OIL ADDITIVE Chevron Oronite Company LLC (US) 2015-05-20 EP disclosed
US-8980806-B2 Preparation of a post-treated molybdenum amide additive composition and lubricating oil compositions containing same CHEVRON ORONITE COMPANY LLC (US) 2015-03-17 US disclosed
US-20090247434-A1 PREPARATION OF A MOLYBDENUM AMIDE ADDITIVE COMPOSITION AND THE LUBRICATING OIL COMPOSITIONS CONTAINING SAME CHEVRON ORONITE COMPANY LLC 2009-10-01 US disclosed
US-4544481-A HYDROTREATMENT OF HYDROCARBONS EXXON RESEARCH AND ENGINEERING CO. (US) 1985-10-01 US disclosed
US-4542121-A Catalysts from molybdenum polysulfide precursors, their preparation and use EXXON RESEARCH AND ENGINEERING CO. (US) 1985-09-17 US disclosed
US-4540481-A HYDROCARBON HYDROTREATMENT EXXON RESEARCH AND ENGINEERING CO. (US) 1985-09-10 US disclosed
US-4457836-A FROM PETROLEUM DISTILLATES EXXON RESEARCH AND ENGINEERING COMPANY (US) 1984-07-03 US disclosed
US-4431747-A HYDROREFINING CATALYSTS; METHANATION; HYDROTREATMENT; IMPREGNATING WITH A ORGANIC AMINE METAL COMPLEX EXXON RESEARCH AND ENGINEERING CO. (US) 1984-02-14 US disclosed
US-4430442-A HYDROREFINING CATALYSTS; CATALYST SELECTIVETY; HYDRODENITROGENIZATION EXXON RESEARCH AND ENGINEERING CO. (US) 1984-02-07 US disclosed
US-4139516-A Process for the preparation of thianthrene compounds HOOKER CHEMICALS & PLASTICS CORP. (US) 1979-02-13 US disclosed
US-4091031-A Process for the manufacture of substituted thianthrene based products HOOKER CHEMICALS & PLASTICS CORP. (US) 1978-05-23 US disclosed
US-4069263-A Process for directed chlorination of alkylbenzenes HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1978-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11758809-B2 Compound, display panel, and display apparatus C1S, C3AR1, DRD3 MAOA 2069/4885MEN1 1065/4885KMT2A 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.